Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ocular Therapeut
(NQ:
OCUL
)
8.820
+0.260 (+3.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocular Therapeut
< Previous
1
2
3
4
5
6
7
Next >
Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2023
April 21, 2023
Via
Benzinga
OKYO Pharma Management Takes Company Stock In Private Placement Instead Of Deferred Pay
April 18, 2023
Drug development can be notoriously slow, and it can take some companies 10 years or more to pass through all the trials and tests required by the Food and Drug Administration (FDA).
Via
Benzinga
Looking Into Ocular Therapeutix's Return On Capital Employed
March 09, 2023
Via
Benzinga
The Latest Analyst Ratings for Ocular Therapeutix
March 07, 2023
Via
Benzinga
Earnings Outlook For Ocular Therapeutix
March 03, 2023
Via
Benzinga
Why Shares of Ocular Therapeutix Jumped This Week
February 16, 2023
A promising report of a therapy in a phase 1 trial gave the stock a lift.
Via
The Motley Fool
OKYO Pharma To Begin Phase 2 Efficacy Trials For Dry Eye Disease Drug Candidate In March 2023, Anticipates Releasing Topline Results By Q4
March 28, 2023
Drug development isn’t known for being fast-paced, and developing any new drug is generally a long process. However, OKYO Pharma Ltd. (NASDAQ: OKYO) is moving quickly to develop its eye treatment drug,...
Via
Benzinga
Dick's Sporting Goods, WW International, Sea Limited And Other Big Stocks Moving Higher On Tuesday
March 07, 2023
U.S. stocks traded lower, with the Dow Jones dropping around 150 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Tesla, Solaredge, Palantir, Cleveland-Cliffs, Ocular Therapeutix: Why These 5 Stocks Are Drawing Heavy Attention Today
February 13, 2023
Major Wall Street indices closed over 1% higher on Monday ahead of the release of the consumer price index report on Tuesday. The Nasdaq Composite closed 1.48% higher while the S&P 500 ended the...
Via
Benzinga
Dow Gains Over 300 Points; S&P 500 Up 1%
February 13, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 300 points on Monday. The Dow traded up 1.01% to 34,211.29 while the NASDAQ rose 1.52% to 11,896.33. The S&P 500...
Via
Benzinga
Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 13, 2023
Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 120.5% to $1.02 after jumping over 72% on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 13, 2023
Via
Benzinga
Nasdaq Rises 1.5%; G1 Therapeutics Shares Plummet
February 13, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1.5% on Monday. The Dow traded up 0.96% to 34,193.83 while the NASDAQ rose 1.52% to 11,896.75. The S&P 500...
Via
Benzinga
Teradata, Monday.Com And Other Big Stocks Moving Higher On Monday
February 13, 2023
U.S. stocks traded higher, with the Dow Jones gaining over 300 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
US Stocks Open Higher; Dow Jumps 200 Points
February 13, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Monday. Following the market opening Monday, the Dow traded up 0.59% to 34,069.23 while the NASDAQ rose 0.65% to...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 13, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
February 13, 2023
It's time to start the week with a breakdown of the biggest pre-market stock movers traders will want to keep a watch on Monday!
Via
InvestorPlace
Ocular Therapeutix Shares Jump On Favorable Data From Intravitreal Implant Study In Wet AMD
February 13, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
December 12, 2022
Monday saw 196 companies set new 52-week lows.
Via
Benzinga
AiViva Reports That Their Promising New Treatment For Wet AMD Is Soon To Be Ready For Clinical Trials
November 14, 2022
Visit https://www.startengine.com/aiviva to invest in AiViva’s StartEngine Campaign.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 08, 2022
During Thursday's trading, 138 companies set new 52-week lows.
Via
Benzinga
Ocular Therapeutix And 2 Other Penny Stocks Insiders Are Aggressively Buying
November 10, 2022
The Dow Jones dipped by more than 600 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
November 09, 2022
Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.
Via
Benzinga
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session
November 08, 2022
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast...
Via
Benzinga
Perrigo, Tripadvisor, Lyft, And Some Other Big Stocks Moving Lower On Tuesday
November 08, 2022
U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Ocular Therapeutix™ to Participate at Three Upcoming Investor Conferences
November 08, 2022
From
Ocular Therapeutix, Inc.
Via
Business Wire
Ocular Therapeutix™ Reports Third Quarter 2022 Financial Results and Business Update
November 07, 2022
From
Ocular Therapeutix, Inc.
Via
Business Wire
A Preview Of Ocular Therapeutix's Earnings
November 04, 2022
Ocular Therapeutix (NASDAQ:OCUL) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Ocular...
Via
Benzinga
Ocular Therapeutix™ To Report Third Quarter 2022 Financial Results
October 24, 2022
From
Ocular Therapeutix, Inc.
Via
Business Wire
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
October 05, 2022
Following insider buying is a savvy way for retail investors to profit even when a bear market is raging on Wall Street. Here are 15 stocks.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.